Stock Worth Mentioning Today: Could Aetna Inc Go Down After Reaching 52-Week High?

Stock Worth Mentioning Today: Could Aetna Inc Go Down After Reaching 52 Week High?

The stock of Aetna Inc (NYSE:AET) hit a new 52-week high and has $132.10 target or 3.00% above today’s $128.25 share price. The 8 months bullish chart indicates low risk for the $44.53B company. The 1-year high was reported on Nov, 22 by If the $132.10 price target is reached, the company will be worth $1.34 billion more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 149,843 shares traded hands. Aetna Inc (NYSE:AET) has risen 12.06% since April 20, 2016 and is uptrending. It has outperformed by 7.50% the S&P500.

Aetna Inc (NYSE:AET) Ratings Coverage

Out of 11 analysts covering Aetna (NYSE:AET), 6 rate it a “Buy”, 0 “Sell”, while 5 “Hold”. This means 55% are positive. $162.0 is the highest target while $12 is the lowest. The $110.33 average target is -13.97% below today’s ($128.25) stock price. Aetna has been the topic of 19 analyst reports since July 30, 2015 according to StockzIntelligence Inc. The rating was maintained by Oppenheimer on Wednesday, August 5 with “Hold”. The stock of Aetna Inc (NYSE:AET) has “Mkt Perform” rating given on Monday, November 14 by Bernstein. RBC Capital Markets maintained the stock with “Outperform” rating in Friday, April 29 report. The company was initiated on Friday, September 23 by Evercore. The rating was downgraded by Wolfe Research to “Peer Perform” on Thursday, July 21. RBC Capital Markets upgraded Aetna Inc (NYSE:AET) on Tuesday, September 8 to “Outperform” rating. RBC Capital Markets maintained Aetna Inc (NYSE:AET) rating on Tuesday, February 2. RBC Capital Markets has “Outperform” rating and $140 price target. The rating was initiated by Bernstein with “Outperform” on Thursday, June 16. The firm has “Buy” rating by Bank of America given on Thursday, July 30. The stock of Aetna Inc (NYSE:AET) has “Hold” rating given on Tuesday, February 2 by Jefferies.

According to Zacks Investment Research, “Aetna Inc. is one of the nation’s largest health benefits companies and one of the nation’s largest insurance and financial services organizations. Aetna provides these benefits to employer and plan sponsor customers in all 50 states, ranging from large multisite national accounts to middle-market and small-employer groups. Its products include the full range of health insurance, including dental and pharmacy benefits, from HMO and POS to PPO and indemnity, as well as group insurance products such as life, disability and long-term care insurance.”

Insitutional Activity: The institutional sentiment decreased to 0.75 in Q2 2016. Its down 0.08, from 0.83 in 2016Q1. The ratio dived, as 50 funds sold all Aetna Inc shares owned while 294 reduced positions. 47 funds bought stakes while 238 increased positions. They now own 313.20 million shares or 5.61% less from 331.82 million shares in 2016Q1.
Balyasny Asset Management Limited Com, a Illinois-based fund reported 172,500 shares. Oz Ltd Partnership, a New York-based fund reported 227,464 shares. Segall Bryant Hamill Lc last reported 2,756 shares in the company. Camarda Fin Advisors Lc has 2% invested in the company for 25,832 shares. Pax World Management reported 14,071 shares or 0.1% of all its holdings. Trexquant Investment L P, a Connecticut-based fund reported 10,500 shares. Hancock Holding Commerce accumulated 141,991 shares or 0.72% of the stock. Rhenman & Prns Asset Management Ab has invested 1.45% of its portfolio in Aetna Inc (NYSE:AET). Nikko Asset Mngmt Americas, a New York-based fund reported 4,500 shares. Blackrock Ltd, a United Kingdom-based fund reported 4.66M shares. Moreover, First Fincl In has 0.06% invested in Aetna Inc (NYSE:AET) for 876 shares. Martingale Asset Mgmt Limited Partnership accumulated 2,248 shares or 0% of the stock. Ingalls & Snyder Ltd Liability Com holds 0.02% or 2,300 shares in its portfolio. Seabridge Investment Advsrs reported 489 shares or 0.02% of all its holdings. Transamerica Fincl Advsrs, a Florida-based fund reported 23,278 shares.

Insider Transactions: Since August 22, 2016, the stock had 0 insider purchases, and 5 sales for $12.76 million net activity. Coye Molly Joel also sold $100,820 worth of Aetna Inc (NYSE:AET) shares. GUERTIN SHAWN M sold 45,328 shares worth $5.45 million. $827,214 worth of Aetna Inc (NYSE:AET) shares were sold by GARTEN JEFFREY E. Another trade for 45,000 shares valued at $5.38 million was sold by Lynch Karen S. 9,150 shares were sold by SOISTMAN FRANCIS S JR, worth $1.00M on Monday, November 7.

More news for Aetna Inc (NYSE:AET) were recently published by:, which released: “Aetna Revenue and Profit Rise” on October 27, 2016.‘s article titled: “Aetna Still Undecided On Coverage For Sarepta’s Highly Debated Muscular …” and published on November 21, 2016 is yet another important article.

AET Company Profile

Aetna Inc., incorporated on December 20, 1982, is a diversified healthcare benefits company. The Firm offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare supplement plans, workers’ compensation administrative services and health information technology services and products, such as accountable care solutions (ACS). The Firm operates through three divisions: Health Care, Group Insurance and Large Case Pensions. The Company’s clients include employer groups, individuals, college students, part-time and hourly workers, health plans, healthcare providers (providers), Governmental units, Government-sponsored plans, labor groups and expatriates.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment